Adaptimmune Therapeutics PLC (NASDAQ:ADAP) Q3 2019 Earnings Conference Call November 6, 2019 8:00 AM ET Company Participants Juli Miller - Director, IR Adrian Rawcliffe - CEO, Principal Accounting Officer & Director Elliot Norry - Acting Chief Medical Officer John Lunger - Chief Patient Supply Officer Michael Garone - Interim CFO Conference Call Participants Mohit Bansal - Citigroup Marc Frahm - Cowen and Company Tony Butler - Roth Capital Partners Nicholas Abbott - Wells Fargo Securities Michael Schmidt - ...